TGFB1 and renal fibrosis: The results showed that tropisetron could ameliorate kidney function and attenuate renal fibrosis by inhibiting the expressions of TGF-β1 and p53 proteins, as well increasing the level of extracellular matrix metalloproteinases, including MMP-9 and MMP-2 (Pourheydar et al., 2021).